HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Donna L Berry Selected Research

Ambulatory Care (Outpatient Care)

1/2022Self-Reported Severity, Characteristics, and Functional Limitations of Chemotherapy-Induced Peripheral Neuropathy.
3/2021Exploring the impact of a decision support algorithm to improve clinicians' chemotherapy-induced peripheral neuropathy assessment and management practices: a two-phase, longitudinal study.
11/2017Psychosocial outcomes of an electronic self-report assessment and self-care intervention for patients with cancer: a randomized controlled trial.
1/2017Clinician perspectives on symptom and quality of life experiences of patients during cancer therapies: Implications for eHealth.
11/2015Screening for Pain in the Ambulatory Cancer Setting: Is 0-10 Enough?
3/2014Patient and clinician communication of self-reported insomnia during ambulatory cancer care clinic visits.
9/2012Incidence of severe pain in newly diagnosed ambulatory patients with stage IV cancer.
7/2012Factors associated with pain among ambulatory patients with cancer with advanced disease at a comprehensive cancer center.
5/2011Provider verbal responses to patient distress cues during ambulatory oncology visits.
3/2011Enhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Donna L Berry Research Topics

Disease

31Neoplasms (Cancer)
04/2022 - 09/2004
12Prostatic Neoplasms (Prostate Cancer)
01/2022 - 03/2003
10Pain (Aches)
01/2022 - 06/2006
7Peripheral Nervous System Diseases (PNS Diseases)
03/2022 - 09/2012
3Cancer Pain
10/2022 - 06/2003
3Hypesthesia (Numbness)
01/2022 - 03/2021
3Vomiting
01/2022 - 02/2015
3Nausea
01/2022 - 02/2015
2Stress Urinary Incontinence
02/2022 - 01/2022
2Breast Neoplasms (Breast Cancer)
09/2021 - 01/2020
1Urinary Incontinence
01/2022
1Erectile Dysfunction
01/2022
1Multiple Myeloma
03/2021
1Heart Failure
03/2018
1Alzheimer Disease (Alzheimer's Disease)
01/2018
1Cachexia
01/2018
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2018
1Anorexia
01/2018
1Cognitive Dysfunction
01/2018
1Ovarian Neoplasms (Ovarian Cancer)
12/2017
1Hypersensitivity (Allergy)
04/2017
1Chronic Pain
01/2016
1Back Pain (Backache)
01/2016
1Lung Neoplasms (Lung Cancer)
07/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2015
1Mouth Neoplasms (Oral Cancer)
01/2015
1Sleep Initiation and Maintenance Disorders (Insomnia)
03/2014
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
07/2012
1Prostatic Intraepithelial Neoplasia
11/2011
1Hematologic Neoplasms (Hematological Malignancy)
02/2010

Drug/Important Bio-Agent (IBA)

5AndrogensIBA
01/2021 - 06/2006
3SDMIBA
01/2022 - 08/2011
2AntiemeticsIBA
01/2022 - 05/2017
2Taxoids (Taxanes)IBA
09/2021 - 03/2021
2Prostate-Specific Antigen (Semenogelase)IBA
04/2013 - 06/2006
1ElementsIBA
12/2021
1Proteasome InhibitorsIBA
09/2021
1Bortezomib (Velcade)FDA Link
03/2021
1Testosterone (Sustanon)FDA Link
01/2021
1Androgen Receptors (Androgen Receptor)IBA
01/2021
1taxaneIBA
04/2017
1Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2015
1TabletsIBA
07/2014
1Androgen Antagonists (Antiandrogens)IBA
04/2013
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
04/2013
1Hormones (Hormone)IBA
04/2013
1Pain-FreeIBA
09/2012
1AntigensIBA
02/2012
1SeleniumIBA
11/2011
1Selenomethionine (Sethotope)FDA Link
11/2011
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
09/2011
1amsonic acid (DAS)IBA
08/2011
1EstramustineFDA Link
06/2006
1Mitoxantrone (Novantrone)FDA LinkGeneric
06/2006
1Prednisone (Sone)FDA LinkGeneric
06/2006
1Analgesics (Analgesic Drugs)IBA
06/2006
1Docetaxel (Taxotere)FDA Link
06/2006

Therapy/Procedure

18Therapeutics
09/2021 - 05/2011
15Drug Therapy (Chemotherapy)
03/2022 - 07/2012
11Ambulatory Care (Outpatient Care)
01/2022 - 03/2003
4Radiotherapy
03/2016 - 09/2004
3Palliative Care (Palliative Therapy)
10/2022 - 03/2005
2Pain Management
10/2022 - 06/2003
2Aftercare (After-Treatment)
04/2022 - 11/2017
2Suburethral Slings (Tension-Free Vaginal Tape)
02/2022 - 01/2022
2Prostatectomy (Retropubic Prostatectomy)
01/2022 - 01/2021
1Music Therapy
04/2022
1Contraindications
01/2021
1Mastectomy (Mammectomy)
01/2020
1Terminal Care (Care, Terminal)
11/2017
1Premedication
04/2017
1Tai Ji (Tai Chi Chuan)
01/2016
1Continuity of Patient Care
01/2014
1Castration
04/2013
1Cell Transplantation
02/2010